Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.89M Sell
950
-287
-23% -$457K 0.19% 103
2026
Q1
$1.63M Sell
1,237
-2
-0.2% -$2.74K 0.19% 99
2025
Q4
$1.33M Sell
1,239
-214
-15% -$223K 0.15% 116
2025
Q3
$1.41M Buy
1,453
+33
+2% +$25.9K 0.16% 111
2025
Q2
$1.14M Sell
1,420
-271
-16% -$194K 0.14% 121
2025
Q1
$1.12M Buy
1,691
+231
+16% +$168K 0.16% 112
2024
Q4
$1.01M Buy
+1,460
New +$1.05M 0.15% 112

Other funds holding ASML

Novem Group's ASML Position: Q2 2026 in Review

Novem Group reduced its ASML (ASML) stake by 23% in Q2 2026, selling an estimated $457K and leaving 950 shares worth $1.89M. The position accounts for 0.19% of the portfolio, ranked #103.

Novem Group first reported a position in ASML in Q4 2024 and has held it in 7 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Novem Group held 950 shares of ASML worth $1.89M as of Q2 2026.
  • Novem Group sold 287 ASML shares in Q2 2026, an estimated $457K.
  • ASML made up 0.19% of Novem Group's portfolio in Q2 2026, its #103 holding.
  • Novem Group first reported a position in ASML in Q4 2024 and has held it in 7 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.